Edition:
United Kingdom

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

2.04USD
8:58pm BST
Change (% chg)

$-0.10 (-4.67%)
Prev Close
$2.14
Open
$2.11
Day's High
$2.12
Day's Low
$2.03
Volume
20,046
Avg. Vol
23,075
52-wk High
$3.47
52-wk Low
$1.36

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $43.83
Shares Outstanding(Mil.): 20.48
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -0.67 -- --
ROI: -28.96 7.41 11.59
ROE: -49.97 7.88 16.33

Earnings vs. Estimates